Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 5/20 | 0.40 |
| ▸ | CNR1 | P21554 | 4/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1131931 | 1.00 | NR1H4 (0.40) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131302 | 0.93 | FFAR1 (0.39) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131301 | 0.93 | FFAR1 (0.39) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131288 | 0.86 | FFAR1 (0.39) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131291 | 0.86 | FFAR1 (0.39) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1132049 | 0.85 | PTPN11 (0.37) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131724 | 0.85 | PTPN11 (0.37) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131312 | 0.84 | CMKLR1 (0.38) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131311 | 0.84 | CMKLR1 (0.38) | NR1H4CNR1CNR2FFAR1FFAR4 | |
| SCHEMBL1131560 | 0.81 | ALOX5 (0.43) | NR1H4KMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663105-B1 | CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS | BRISTOL MYERS SQUIBB CO (US) | 2011-02-16 | — | — | EP | claimed |
| EP-1663105-B1 | CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS | BRISTOL MYERS SQUIBB CO (US) | 2011-02-16 | — | — | EP | disclosed |
| EP-1663105-B1 | CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS | BRISTOL MYERS SQUIBB CO (US) | 2011-02-16 | — | — | EP | disclosed |